PharmaDrug Engages Research Lab To Advance Patented Cocaine Synthesis Method

FULL DISCLOSURE: This content is sponsored by PharmaDrug Inc.

PharmaDrug (CSE: PHRX) has formally engaged a research lab to refine and advance the development of its patented cocaine synthesis process.

The lab, Chiral Logistics Corp, is based in Victoria, BC, where it specializes in chemical synthesis, bio-synthesis, extractions, and isolations of active chemical substances. The research and development lab focuses on operating on a contractual basis to drive innovation in the pharma and biotech sectors.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

The processes developed by the lab will remain as the wholly owned IP of SecureDose, the wholly-owned subsidiary of PharmaDrug that currently holds the IP on the novel cocaine synthesis method.

WATCH: PharmaDrug: A Path To Safe Supply

“We are extremely excited to begin working with Chiral Labs. The work will focus on both fine tuning the process and producing a test batch to prove out our method and formulation. We will also seek to partner with a licensed contract commercial manufacturer to collaborate on tactical commercial methods with a goal to begin producing a larger commercial batch early next year,” commented CEO Robert Steen.

PharmaDrug last traded at $0.035 on the CSE.


FULL DISCLOSURE: PharmaDrug is a client of Canacom Group, the parent company of The Deep Dive. Canacom Group is currently long the equity of PharmaDrug. The author has been compensated to cover PharmaDrug on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

First Majestic Hits 4.24 g/t Gold Over 48.8 Metres at Saval as Jerritt Canyon Restart Advances

First Majestic Lifts Q3 Revenue 38% to US$394.1 Million on Higher Silver Prices

Related News

Red Light Holland, Pharmadrug Enter Share Exchange Agreement

It appears that Red Light Holland (CSE: TRIP) and Pharmadrug Inc (CSE: BUZZ) have entered...

Wednesday, July 15, 2020, 09:45:07 AM

Biosynthetic Cocaine? PharmaDrug Files Patent For Novel Manufacturing Method

PharmaDrug's (CSE: PHRX) subsidiary SecureDose has finally revealed its first biosynthetic formulation: pharmaceutical grade cocaine....
Wednesday, March 13, 2024, 08:45:11 AM

PharmaDrug Names Dr David Kideckel As Chairman, While SecureDose Finalizes Formulation

PharmaDrug (CSE: PHRX) this morning released a series of updates, headlined by the appointment of...
Tuesday, February 27, 2024, 09:44:15 AM

Pharmadrug Completes Super Smart Acquisition, Issues 64.4 Million Free Trading Shares

Pharmadrug Inc (CSE: BUZZ) announced this morning that it has completed its acquisition of Interrobang...

Monday, June 15, 2020, 02:44:06 PM

Khiron Life Sciences Looks To Acquire PharmaDrug’s German Subsidiary For $2.0 Million

Khiron Life Sciences Corp. (TSXV: KHRN) announced today the plan to acquire Pharmadrug GmbH, a...

Tuesday, May 31, 2022, 10:34:00 AM